Côd QR

Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial

Microarray patches (MAPs) have the potential to be a safer, more acceptable, easier-to-use, and more cost-effective means for the administration of vaccines than injection by needle and syringe. Here, we report findings from a randomized, partially double-blinded, placebo-controlled Phase I trial us...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Ben Baker, Imogen M. Bermingham, Indika Leelasena, Julian Hickling, Paul R. Young, David A. Muller, Angus H. Forster
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2023-11-01
Cyfres:Vaccines
Pynciau:
microarray patch (MAP)
high-density microarray patch (HD-MAP)
measles (M)
rubella (R)
vaccine
Phase I
Mynediad Ar-lein:https://www.mdpi.com/2076-393X/11/11/1725
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg